Arrowstreet Capital’s Cabot Corp CBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-29,968
Closed -$2.25M 1898
2025
Q2
$2.25M Buy
+29,968
New +$2.29M ﹤0.01% 1411
2021
Q4
Sell
-326,888
Closed -$16.4M 1464
2021
Q3
$16.4M Sell
326,888
-48,698
-13% -$2.6M 0.02% 583
2021
Q2
$21.4M Sell
375,586
-37,539
-9% -$2.21M 0.03% 581
2021
Q1
$21.7M Sell
413,125
-134,116
-25% -$6.61M 0.03% 563
2020
Q4
$24.6M Sell
547,241
-9,930
-2% -$412K 0.03% 522
2020
Q3
$20.1M Buy
557,171
+518,825
+1,353% +$19.7M 0.03% 553
2020
Q2
$1.42M Sell
38,346
-34,987
-48% -$1.17M ﹤0.01% 1625
2020
Q1
$1.92M Sell
73,333
-157,134
-68% -$5.98M 0.01% 1078
2019
Q4
$11M Buy
+230,467
New +$10.7M 0.03% 586
2019
Q1
Sell
-42,600
Closed -$1.83M 1739
2018
Q4
$1.83M Buy
+42,600
New +$2.12M ﹤0.01% 814
2016
Q4
Sell
-121,461
Closed -$6.37M 1737
2016
Q3
$6.37M Buy
121,461
+5,842
+5% +$289K 0.02% 582
2016
Q2
$5.28M Buy
+115,619
New +$5.39M 0.02% 575
2015
Q1
Sell
-101,197
Closed -$4.44M 1013
2014
Q4
$4.44M Sell
101,197
-38,321
-27% -$1.73M 0.03% 479
2014
Q3
$7.08M Buy
+139,518
New +$7.66M 0.04% 340

Other funds holding CBT

Arrowstreet Capital's CBT Position: Q3 2025 in Review

Arrowstreet Capital sold out of Cabot Corp (CBT) in Q3 2025, closing a stake of 29,968 shares — an estimated $2.25M sold.

Arrowstreet Capital first reported a position in CBT in Q3 2014 and held it in 14 quarters. The position peaked at $24.6M in Q4 2020. 378 funds tracked by Wall St. Rank hold CBT as of Q3 2025.

  • Arrowstreet Capital reported no remaining Cabot Corp position as of Q3 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 29,968 Cabot Corp shares in Q3 2025, an estimated $2.25M.
  • Arrowstreet Capital first reported a position in Cabot Corp in Q3 2014 and held it in 14 quarters.
  • Arrowstreet Capital's Cabot Corp position peaked at $24.6M in Q4 2020.
  • 378 funds tracked by Wall St. Rank held Cabot Corp as of Q3 2025.

Based on Arrowstreet Capital's 13F filing for Q3 2025, filed 13 Nov 2025.